SCHEMBL21698409

SCHEMBL21698409

C=C(CN1CCC(CN)CC1)NC1Cc2cccc(C(=O)O)c2OB1N=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21698361 0.90 NAMPT (0.30) —
SCHEMBL21698406 0.88 — —
SCHEMBL21698403 0.88 ALDH1A1 (0.33) —
SCHEMBL21698482 0.88 — —
SCHEMBL21698465 0.87 — —
SCHEMBL21698364 0.86 ALDH1A1 (0.35) —
SCHEMBL21698464 0.85 HTT (0.31) —
SCHEMBL21698366 0.84 ALDH1A1 (0.32) —
SCHEMBL21698368 0.84 SMYD3 (0.30) —
SCHEMBL21698448 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970340-B1 BETA-LACTAMASE INHIBITORS VENATORX PHARMACEUTICALS INC (US) 2020-02-12 — — EP disclosed
Send feedback